tiprankstipranks
Lineage Cell Therapeutics, Inc. (LCTX)
NYSE MKT:LCTX
Holding LCTX?
Track your performance easily

Lineage Therap (LCTX) Financial Statements

1,855 Followers

Lineage Therap Financial Overview

Lineage Therap's market cap is currently ―. The company's EPS TTM is $-0.11; its P/E ratio is -5.45; Lineage Therap is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 3.78M$ 1.41M$ 1.44M$ 2.07M$ 1.25M
Gross Profit$ 3.74M$ 1.36M$ 1.35M$ 1.82M$ 1.08M
EBIT$ -3.00M$ -5.77M$ -6.56M$ -6.36M$ -6.71M
EBITDA$ -2.86M$ -5.63M$ -6.38M$ -6.19M$ -6.53M
Net Income Common Stockholders$ -3.03M$ -5.76M$ -6.54M$ -1.55M$ -7.11M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 32.71M$ 38.50M$ 43.62M$ 35.49M$ 41.37M
Total Assets$ 96.59M$ 102.80M$ 108.48M$ 101.02M$ 106.15M
Total Debt$ 2.75M$ 2.95M$ 3.25M$ 2.95M$ 3.08M
Net Debt$ -29.96M$ -35.55M$ -40.37M$ -32.54M$ -38.29M
Total Liabilities$ 31.80M$ 35.93M$ 37.49M$ 39.00M$ 39.49M
Stockholders Equity$ 66.19M$ 68.30M$ 72.40M$ 63.42M$ 68.12M
Cash Flow-
Free Cash Flow$ -5.90M$ -5.23M$ -5.82M$ -6.11M$ -5.18M
Operating Cash Flow$ -5.79M$ -5.18M$ -5.78M$ -6.02M$ -5.04M
Investing Cash Flow$ 3.89M$ -8.79M$ -38.00K$ 9.74M$ 2.12M
Financing Cash Flow$ -3.00K$ 105.00K$ 14.02M$ -13.00K$ 807.00K
Currency in USD

Lineage Therap Earnings and Revenue History

Lineage Therap Debt to Assets

Lineage Therap Cash Flow

Lineage Therap Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis